Abstract
Type 2 diabetes is the most prevalent form of diabetes, accounting for approximately 90% of cases. This article examines the current classification, diagnostic criteria for diabetes, and screening recommendations and provides a therapeutic strategy for improving glycemic control in patients with type 2 diabetes.
MeSH terms
-
Comorbidity
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / epidemiology
-
Diabetes Mellitus, Type 2 / physiopathology
-
Diabetes Mellitus, Type 2 / therapy*
-
Exercise Therapy
-
Glycoside Hydrolase Inhibitors
-
Humans
-
Hyperlipidemias / epidemiology
-
Hypoglycemic Agents / therapeutic use
-
Insulin / therapeutic use
-
Metformin / therapeutic use
-
Sulfonylurea Compounds / therapeutic use
-
Thiazoles / therapeutic use
Substances
-
Glycoside Hydrolase Inhibitors
-
Hypoglycemic Agents
-
Insulin
-
Sulfonylurea Compounds
-
Thiazoles
-
Metformin